The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-Hydroxy-6-((4'-methoxy-[1,1'-biphenyl]-4-yl)oxy)-1-methylpyrimidine-2,4(1H,3H)-dione ID: ALA4531433
PubChem CID: 129907295
Max Phase: Preclinical
Molecular Formula: C18H16N2O5
Molecular Weight: 340.34
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(-c2ccc(Oc3cc(=O)n(O)c(=O)n3C)cc2)cc1
Standard InChI: InChI=1S/C18H16N2O5/c1-19-17(11-16(21)20(23)18(19)22)25-15-9-5-13(6-10-15)12-3-7-14(24-2)8-4-12/h3-11,23H,1-2H3
Standard InChI Key: UBSXFUQYVXJAEL-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
10.4059 -26.0933 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.1216 -26.5036 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1242 -27.3286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8399 -27.7389 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8424 -28.5639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5531 -27.3242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2688 -27.7345 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9820 -27.3198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6978 -27.7301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4110 -27.3155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4084 -26.4905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1216 -26.0758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8374 -26.4861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5506 -26.0714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5481 -25.2464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2613 -24.8317 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.9770 -25.2420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8323 -24.8361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1191 -25.2508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6927 -26.0802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9795 -26.4948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5506 -26.4992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8348 -26.0889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8323 -25.2639 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4110 -27.7433 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
4 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 1 0
15 18 1 0
18 19 2 0
12 19 1 0
11 20 1 0
20 21 2 0
8 21 1 0
6 22 2 0
22 23 1 0
2 23 1 0
23 24 2 0
3 25 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 340.34Molecular Weight (Monoisotopic): 340.1059AlogP: 2.25#Rotatable Bonds: 4Polar Surface Area: 82.69Molecular Species: ACIDHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 5.44CX Basic pKa: ┄CX LogP: 2.79CX LogD: 0.97Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.74Np Likeness Score: -0.20
References 1. Tang J, Liu F, Nagy E, Miller L, Kirby KA, Wilson DJ, Wu B, Sarafianos SG, Parniak MA, Wang Z.. (2016) 3-Hydroxypyrimidine-2,4-diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design, Synthesis, and Biochemical Evaluations., 59 (6): [PMID:26927866 ] [10.1021/acs.jmedchem.5b01879 ]